MKMarcel Kordt

Marcel Kordt

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marcel Kordt has a total of 45 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Gas Plasma Exposure Attenuates the Inflammatory Rheumatoid Arthritis‐Like Phenotype of Murine Synoviocytes in Vitro

    by Marcel Kordt, Wendy Bergmann‐Ewert, Johann Aleith, Sander Bekeschus, Brigitte Müller‐Hilke

    Rheumatoid arthritis (RA) is driven by hyperplastic fibroblast‐like synoviocytes (FLS) that adopt a persistent inflammatory and invasive phenotype, often resistant to conventional therapies. Here, we investigated whether cold gas plasma exposure modulates inflammatory FLS (iFLS) in vitro. Primary murine FLS were primed with TNF‐α to induce an inflammatory phenotype and exposed to an argon plasma jet for 30–150 s; argon gas alone served as a control. Gas plasma treatment caused a rapid, dose‐dependent rise in intracellular reactive oxygen species and free thiols, followed by partial resolution by 24 h. This oxidative burst coincided with mitochondrial dysfunction and progressive loss of cell viability. Surviving iFLS exhibited markedly reduced inflammatory features, such as surface levels of ICAM‐1 (CD54), VCAM‐1 (CD106), and Thy‐1 (CD90.2), along with diminished production of IL‐6 and CCL2 at higher doses. Reflecting the impaired expression of inflammation‐associated adhesion molecules. Furthermore, plasma treatment significantly delayed iFLS migration. Together, these findings suggest that cold gas plasma has cytotoxic effects on a subset of iFLS induced by acute oxidative stress, as well as reprogramming surviving iFLS towards a less aggressive phenotype. These in vitro data establish a foundation for further research in synovial explants and arthritis models, as well as for systematic safety testing in non‐inflammatory joint‐resident cells.


  • Open Access

    Synergistic effect of cold gas plasma and experimental drug exposure exhibits skin cancer toxicity in vitro and in vivo

    by Lars Boeckmann, Julia Berner, Marcel Kordt, Elea Lenz, Mirijam Schäfer, Marie–Luise Semmler, Anna Frey, Sanjeev Kumar Sagwal, Henrike Rebl, Lea Miebach, et al.


  • Open Access

    A Sensitive LC-MS/MS Method for the Simultaneous Determination of Two Thia-Analogous Indirubin N-Glycosides and Indirubin-3′-Monoxime in Plasma and Cell Culture Medium

    by Alica Fischle, Rico Schwarz, Franziska Wendt, Marcel Kordt, Robert Ramer, Lars Boeckmann, Martin Hein, Peter Langer, Steffen Emmert, Brigitte Vollmar, et al.

    Indirubin was identified as an active component of Danggui Longhui Wan, an herbal mixture used in traditional Chinese medicine, and showed anticancer activity in clinical trials in patients with chronic leukemia. Investigations on the mechanisms of antitumor action of indirubins have mainly focused on the indirubin derivative indirubin-3′-monoxime (I3M). Meanwhile, antiproliferative and cytotoxic properties on cancer cells have also been demonstrated for several synthetic indirubin N-glycosides. In the present study, we demonstrate cytotoxic activity of the thia-analogous indirubin N-glycosides KD87 (3-[3′-oxo-benzo[b]thiophen-2′-(Z)-ylidene]-1-(β-d-glucopyranosyl)-oxindole) and KD85 (3-[3′-oxo-benzo[b]thiophen-2′-(Z)-ylidene]-1-(β-d-mannopyranosyl)-oxindole) against melanoma and squamous cell carcinoma cells as well as lung cancer and glioblastoma cells. The advanced state of preclinical studies on the effects of indirubins conducted to date underscores the need for pharmacokinetic data from cellular, animal, and human studies for which reliable quantification is required. Therefore, a sensitive liquid chromatography-tandem mass spectrometric (LC-MS/MS) method was developed and validated for the simultaneous measurement of KD87, KD85, and I3M in plasma and cell culture medium. Experimental conditions for sample preparation were optimized for human plasma protein precipitation and liquid-liquid extraction from plasma and cell culture medium. The methods were successfully validated in accordance with the U.S. Food and Drug Administration Bioanalytical Method Validation and evaluated for selectivity, sensitivity, matrix effect, recovery, carryover, calibration curve linearity, accuracy, precision, and stability. The applicability of the methods was demonstrated by the determination of KD87 in mouse plasma after prior intraperitoneal administration to mice.


  • Open Access

    Diagnostic Ability of Methods Depicting Distress of Tumor-Bearing Mice

    by Wentao Xie, Marcel Kordt, Rupert Palme, Eberhard Grambow, Brigitte Vollmar, Dietmar Zechner

    Subcutaneous tumor models in mice are the most commonly used experimental animal models in cancer research. To improve animal welfare and the quality of scientific studies, the distress of experimental animals needs to be minimized. For this purpose, one must assess the diagnostic ability of readout parameters to evaluate distress. In this study, we evaluated different noninvasive readout parameters such as body weight change, adjusted body weight change, faecal corticosterone metabolites concentration, burrowing activity and a distress score by utilising receiver operating characteristic curves. Eighteen immunocompromised NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ mice were used for this study; half were subcutaneously injected with A-375 cells (human malignant melanoma cells) that resulted in large tumors. The remaining mice were inoculated with SCL-2 cells (cutaneous squamous cell carcinoma cells), which resulted in small tumors. The adjusted body weight and faecal corticosterone metabolites concentration had a high diagnostic ability in distinguishing between mice before cancer cell injection and mice bearing large tumors. All other readout parameters had a low diagnostic ability. These results suggest that adjusted body weight and faecal corticosterone metabolites are useful to depict the distress of mice bearing large subcutaneous tumors.


  • Open Access

    Multimodal Imaging Techniques to Evaluate the Anticancer Effect of Cold Atmospheric Pressure Plasma

    by Marcel Kordt, Isabell Trautmann, Christin Schlie, Tobias Lindner, Jan Stenzel, Anna Schildt, Lars Boeckmann, Sander Bekeschus, Jens Kurth, Bernd J. Krause, et al.

    Background: Skin cancer is the most frequent cancer worldwide and is divided into non-melanoma skin cancer, including basal cell carcinoma, as well as squamous cell carcinoma (SCC) and malignant melanoma (MM). Methods: This study evaluates the effects of cold atmospheric pressure plasma (CAP) on SCC and MM in vivo, employing a comprehensive approach using multimodal imaging techniques. Longitudinal MR and PET/CT imaging were performed to determine the anatomic and metabolic tumour volume over three-weeks in vivo. Additionally, the formation of reactive species after CAP treatment was assessed by non-invasive chemiluminescence imaging of L-012. Histological analysis and immunohistochemical staining for Ki-67, ApopTag®, F4/80, CAE, and CD31, as well as protein expression of PCNA, caspase-3 and cleaved-caspase-3, were performed to study proliferation, apoptosis, inflammation, and angiogenesis in CAP-treated tumours. Results: As the main result, multimodal in vivo imaging revealed a substantial reduction in tumour growth and an increase in reactive species after CAP treatment, in comparison to untreated tumours. In contrast, neither the markers for apoptosis, nor the metabolic activity of both tumour entities was affected by CAP. Conclusions: These findings propose CAP as a potential adjuvant therapy option to established standard therapies of skin cancer.